RecruitingNCT06876857
University of Central Florida CereBank
Sponsor
University of Central Florida
Enrollment
50,000 participants
Start Date
Feb 25, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
Millions of persons are affected by brain diseases. The CereBank will be used to support research studies aimed at improving the diagnosis and treatment of brain diseases. Brain diseases can be inherited; developed due to diseases or aging; or can be due to trauma. The Central Florida does not have a brain biobank to meet the needs of research. Therefore, it is necessary for the University of Central Florida to establish a brain biobank.
Eligibility
Sex: FEMALEMin Age: 18 Years
Inclusion Criteria2
- Be 18 years or older.
- Able to provide informed consent. Persons who are unable to provide an informed consent will need a Legally Authorized Representative (LAR) to sign the informed consent.
Exclusion Criteria3
- minors (under age 18).
- prisoners.
- pregnant women.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06876857
Related Trials
Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application
NCT036781941 location
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
NCT05508789141 locations
Impact of COVID-19 Vaccines on Cerebrovascular Health
NCT049921951 location
CUHK Brain Health Longitudinal Study
NCT035925632 locations
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
NCT039113883 locations